Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

Analysts at Citigroup initiated coverage on Qorvo Inc (NASDAQ: QRVO) with a Neutral rating. Qorvo shares closed at $45.05 on Wednesday.

Analysts at RBC Capital initiated coverage on Photronics, Inc. (NASDAQ: PLAB) with a Buy rating. The target price for Photronics is set to $12. Photronics shares closed at $9.06 on Wednesday.

Analysts at Baird initiated coverage on SPX Flow Inc (NYSE: FLOW) with a Outperform rating. The target price for SPX Flow is set to $40. SPX Flow shares closed at $34.43 on Wednesday.

Analysts at Mizuho Securities initiated initiated coverage on Kindred Healthcare, Inc. (NYSE: KND) with a Neutral rating. The target price for Kindred Healthcare is set to $16.75. Kindred Healthcare shares closed at $15.75 on Wednesday.

Analysts at Citigroup initiated coverage of Skyworks Solutions Inc (NASDAQ: SWKS) with a Buy rating. Skyworks Solutions shares closed at $84.07 on Wednesday.

RBC Capital initiated coverage on SPX Flow Inc (NYSE: FLOW) with a Underperform rating. The target price for SPX Flow is set to $32. SPX Flow shares closed at $34.43 on Wednesday.

Sidoti & Co. initiated coverage of Nuveen Build America Bond Opp Fund (NYSE: NBD) with a Buy rating. The target price for Nuveen Build America Bond Opp Fund is set to $43. Nuveen Build America Bond Opp Fund shares closed at $19.42 on Wednesday.

Analysts at H.C. Wainwright initiated coverage of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) with a Buy rating. The target price for Synergy Pharmaceuticals is set to $20. Synergy Pharmaceuticals shares closed at $5.28 on Wednesday.

Compass Point initiated coverage on First Niagara Financial Group Inc. (NASDAQ: FNFG) with a Buy rating. The target price for First Niagara Financial is set to $12. First Niagara Financial shares closed at $10.21 on Wednesday.

Analysts at H.C. Wainwright initiated coverage on Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) with a Buy rating. The target price for Oramed Pharmaceuticals is set to $24. Oramed Pharmaceuticals shares closed at $5.47 on Wednesday.

Latest Ratings for QRVO

DateFirmActionFromTo
Jan 2021Raymond JamesMaintainsOutperform
Dec 2020Morgan StanleyMaintainsOverweight
Dec 2020RosenblattInitiates Coverage OnNeutral

View More Analyst Ratings for QRVO
View the Latest Analyst Ratings

 

Related Articles (PLAB + QRVO)

View Comments and Join the Discussion!

Posted-In: Top InitiationsInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
UFSB of A SecuritiesUpgrades40.0
WSMMorgan StanleyUpgrades
UTZStephens & Co.Initiates Coverage On27.0
NFLXRosenblattMaintains450.0
SNOWRosenblattInitiates Coverage On285.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com